AstraZeneca PLC (AZNN) — Capital Reinvestment Ratio
AstraZeneca PLC (AZNN) has a Capital Reinvestment Ratio of 0.55x as of December 2025, meaning it reinvests 1% of its operating cash flow (MX$2.34 Billion) in capital expenditures (MX$1.29 Billion). Check AstraZeneca PLC (AZNN) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AstraZeneca PLC Capital Reinvestment Ratio (2014–2025)
This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see AZNN cash generation efficiency.
Annual Capital Reinvestment Ratio for AstraZeneca PLC (2014–2025)
Year-by-year Capital Reinvestment Ratio for AstraZeneca PLC from 2014 to 2025. See how much free cash does AstraZeneca PLC generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | MX$14.57 Billion | MX$5.91 Billion | ▲ +4.8% |
| 2024 | 0.39x | MX$11.86 Billion | MX$4.59 Billion | ▲ +18.3% |
| 2023 | 0.33x | MX$10.36 Billion | MX$3.39 Billion | ▲ +193.7% |
| 2022 | 0.11x | MX$9.81 Billion | MX$1.09 Billion | ▼ -39.2% |
| 2021 | 0.18x | MX$5.96 Billion | MX$1.09 Billion | ▼ -8.6% |
| 2020 | 0.20x | MX$4.80 Billion | MX$961.00 Million | ▼ -39.3% |
| 2019 | 0.33x | MX$2.97 Billion | MX$979.00 Million | ▼ -17.2% |
| 2018 | 0.40x | MX$2.62 Billion | MX$1.04 Billion | ▲ +7.5% |
| 2017 | 0.37x | MX$3.58 Billion | MX$1.33 Billion | ▼ -33.6% |
| 2016 | 0.56x | MX$4.14 Billion | MX$2.31 Billion | ▲ +39.7% |
| 2015 | 0.40x | MX$3.32 Billion | MX$1.33 Billion | ▲ +178.6% |
| 2014 | 0.14x | MX$7.06 Billion | MX$1.01 Billion | — |